US 10519222
Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region
granted A61KA61K39/42A61K45/06
Quick answer
US patent 10519222 (Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K39/42, A61K45/06, A61P, A61P31/18